IDRx, a new biotech startup, raises $122M to develop better cancer drug combinations
BioPharma
Source: biopharmadive.com
📰 Ben Auspitz News
Ben Auspitz News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ben Auspitz. Real-time updates on events, politics, business and more.
IDRx Raises $122M in Series A Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Aiming to bring drug combos into earlier lines of cancer therapy, IDRx lands $122M
Taking inspiration from the success of drug cocktails that halt viral infections, startup IDRx aims to develop cancer drug combinations that stop tumor escape. The company, founded by serial entrepreneur Alexis Borisy, has set gastrointestinal stromal tumor (GIST) as its first disease target.
Source: medcitynews.com